A securities fraud class action lawsuit against Stride, Inc. (NYSE: LRN) is moving forward, and a crucial deadline is drawing near. Bernstein Liebhard LLP, the firm leading the action, is inviting investors who purchased shares between October 22, 2024, and October 28, 2025, to assess their legal rights and potential claims.

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against RxSight, Inc., claiming that top executives made false and misleading statements in violation of federal securities laws. Investors who suffered substantial losses are encouraged to join the lawsuit before the September 22, 2025 deadline.

A father and son have been sentenced for orchestrating a multimillion-dollar fraud involving a small New Jersey deli. The scheme, which inflated the deli’s market value to over $100 million, highlights a sophisticated manipulation of stock prices that deceived investors and institutions alike.